NPI: 1427307206 · FOUNTAIN VALLEY, CA 92708 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/07/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/07/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,338 | $1.28M |
| 2019 | 30,678 | $1.39M |
| 2020 | 34,381 | $1.47M |
| 2021 | 30,870 | $1.26M |
| 2022 | 26,979 | $1.21M |
| 2023 | 13,152 | $1.40M |
| 2024 | 4,164 | $1.03M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 59,758 | 4,861 | $7.62M |
| A4657 | Syringe, with or without needle, each | 2,080 | 1,747 | $832K |
| J1270 | Injection, doxercalciferol, 1 mcg | 26,643 | 2,334 | $167K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,259 | 683 | $130K |
| 0250 | 3,294 | 467 | $115K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 46,839 | 2,983 | $70K |
| J1756 | Injection, iron sucrose, 1 mg | 10,303 | 2,637 | $63K |
| 82728 | 1,168 | 1,079 | $23K | |
| 90677 | 31 | 29 | $4K | |
| 90674 | 125 | 125 | $4K | |
| 83970 | 1,217 | 1,130 | $4K | |
| G0008 | Administration of influenza virus vaccine | 87 | 87 | $2K |
| 82108 | 143 | 136 | $681.59 | |
| 90662 | 64 | 64 | $553.70 | |
| 90661 | 14 | 14 | $431.08 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 296 | 247 | $93.40 |
| 83550 | 1,358 | 1,190 | $57.69 | |
| 83540 | 1,347 | 1,178 | $45.29 | |
| 85041 | 1,793 | 1,524 | $21.27 | |
| 85048 | 1,780 | 1,508 | $10.29 | |
| 0634 | 1,097 | 55 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 14 | 13 | $0.00 |
| 0301 | 79 | 27 | $0.00 | |
| 0064A | 15 | 15 | $0.00 | |
| 0821 | 63 | 52 | $0.00 | |
| 0636 | 577 | 45 | $0.00 | |
| 0270 | 39 | 36 | $0.00 | |
| 0305 | 79 | 33 | $0.00 |